quarta-feira, 7 de outubro de 2026
PesquisarExplore
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· April 15, 2026

The Dow Is Back in Positive Territory for 2026. Here Is the Bigger Picture for Investors Who Held Through the Volatility.

View original at finance.yahoo.com
The Dow Is Back in Positive Territory for 2026. Here Is the Bigger Picture for Investors Who Held Through the Volatility. On March 27, the Dow Jones Industrial Average(DJINDICES: ^DJI) closed the week down 6% on the year and about 10% below its all-time high…
Opening lines of the source · short snapshot — read the full document at the original

O que extraímos desta fonte

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Geopolitical events tend to be short-term and recoveries can be relatively short compared to typical recessions

    60% confidence
  • The average recovery time from a 10% to 20% correction is eight months

    60% confidence
  • Timing the market can be especially dangerous and usually fruitless during geopolitical events

    60% confidence
  • Since 1949, market corrections of at least 10% happen on average every 2.5 years

    60% confidence
  • Investors are usually best served by sitting tight during market corrections

    60% confidence
  • AI could create the world's first trillionaire

    60% confidence
  • The average recovery time from a 5% to 10% downturn is three months

    60% confidence
O que sabemos · a inteligência por trás desta página
Ao vivo do substrato
O que estamos a ver
Obesity and Immunology Readouts, Big Pharma M&A and AI-Designed Drugs Converge Into a Q4 2026 Catalyst Wave
Late-stage data and deal activity are clustering ahead of Q4 2026. Novo Nordisk's CagriSema won Best Abstract at EASD 2026 for its brain and body (fMRI/MRI) data, Lilly showed ADtouch results for EBGLYSS and agreed to buy Merida Biosciences for $2.9B, and Merck's tulisokibart hit its Phase 2b endpoints. A key regulatory catalyst follows: the FDA PDUFA date for the ivonescimab BLA on 2026-11-14. AI-designed rentosertib showing anti-aging effects adds a speculative AI-drug-discovery thread, while QAIAx's microcities trial and QIII pilot (planned 2027-01-01) are peripheral, forecast-only items.
A nossa leitura dos dados ›
Sinais que acompanhamos
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Padrões que observamos ›
Onde as fontes divergem
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
Sinalizamos conflitos abertamente ›
Verificado recentemente
✓ Verificado com a fonte original
4,986
factos rastreados à sua fonte — e sinalizamos os que não se confirmam.
101 entidades acompanhadas4,986 factos verificados com a fonte5,351 documentos-fonte arquivados
Consulte estes dados → isubstrate.com
The Dow Is Back in Positive Territory for 2026. Here Is the Bigger Picture for Investors Who Held Through the Volatility. — Source | Via News | pt.VIA.NEWS